NL

Nigel Lange

Oncosil Medical Limited | Chief Executive Officer, Managing Director
Mr Lange brings with him over 30 years of experience in the medical devices industry. Since 2003, Nigel has held various leadership roles with Sirtex Medical, a global leader in brachytherapy treatment for liver cancer. From 2003, Nigel served as Chief Executive Officer of Sirtex's European business, responsible for establishing their brachytherapy device in over 300 centres across Europe and Middle East.

Company and Roles

Company
Title
Tenure
Since
OSL
Oncosil Medical Limited
  • Chief Executive Officer
  • Managing Director
3yrs, 5mthJan 2021

Holding

Company
Last Notice
Direct Shares
Indirect Shares
Options
Convertibles
OSL
Oncosil Medical Limited
31/08/2312,936,606N/A1,000,000N/A

Transactions

Company
Date
Type
Amount
Price
Value
Notes
OSL
Oncosil Medical Limited
19/12/23
Issued
91,500,000$0.004$366,000Issue of securities
OSL
Oncosil Medical Limited
11/05/23
Issued
1,000,000$0.010$10,000Rights issue
OSL
Oncosil Medical Limited
11/05/23
Issued
1,000,000$0.010$10,000Rights issue
OSL
Oncosil Medical Limited
25/10/22
Issued
2,469,795$0.050$123,489Issue of securities
OSL
Oncosil Medical Limited
10/06/22
Issued
500,000$0.050$25,000Rights issue